Walvax Biotechnology Market Cap

Walvax Biotechnology has a market cap or net worth of 22.69 billion as of May 19, 2026. Its market cap has increased by 31.51% in one year.

Market Cap

22.69B

Enterprise Value

23.49B

Revenue

2.40B

Ranking

n/a

PE Ratio

79.97

Stock Price

14.22

Market Cap Chart

Since November 12, 2010, Walvax Biotechnology's market cap has increased from 13.63B to 22.69B, an increase of 66.44%. That is a compound annual growth rate of 3.34%.

Market Cap History

Date	Market Cap	% Change
May 18, 2026	22.36B	28.14%
Dec 31, 2025	17.45B	-9.69%
Dec 31, 2024	19.32B	-48.62%
Dec 29, 2023	37.60B	-41.50%
Dec 30, 2022	64.27B	-28.12%
Dec 31, 2021	89.42B	50.25%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Livzon Pharmaceutical Group	25.22B
Zhejiang Huahai Pharmaceutical	24.11B
Dizal (Jiangsu) Pharmaceutical	23.64B
Kangmei Pharmaceutical	22.26B
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd	21.90B
Hybio Pharmaceutical	21.47B
Tasly Pharmaceutical Group	21.47B
Jiangsu Nhwa Pharmaceutical Co., LTD	20.89B

Market Cap Rankings